Clinical Trials Logo

Anembryonic Pregnancy clinical trials

View clinical trials related to Anembryonic Pregnancy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05216952 Completed - Missed Abortion Clinical Trials

Ulipristal Acetate for Use in Early Pregnancy Loss

Start date: May 11, 2022
Phase: Phase 2
Study type: Interventional

The investigators will study the feasibility of using 90mg ulipristal acetate, a selective progesterone receptor agonist, as an adjunct to 800mcg vaginal misoprostol for the medical management of early pregnancy loss. Patients will be followed to assess effective treatment of early pregnancy loss, additional interventions needed, side effects, adverse events and patient acceptability.

NCT ID: NCT05198050 Completed - Clinical trials for Anembryonic Pregnancy

Letrozole in Induction of Abortion of Anembryonic Pregnancy

Start date: April 3, 2022
Phase: N/A
Study type: Interventional

Some studies suggest the prescription of aromatase inhibitors prior to the use of misoprostol for inducing drug abortion. the aim of the study is to compare the effectiveness of various regimens of letrozole combined with misoprostol versus using misoprostol alone in inducing complete abortion in patients with blighted ovum.

NCT ID: NCT00468299 Terminated - Miscarriage Clinical Trials

MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure

MiMi
Start date: April 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two combinations of drugs (mifepristone and misoprostol versus placebo and misoprostol) used for medical treatment for early pregnancy failure. We will compare the two combinations of medications to see which combination makes miscarriage happen faster. We hypothesize that there will be no difference in time to complete miscarriage between the two groups.

NCT ID: NCT00177372 Completed - Clinical trials for Anembryonic Pregnancy

Mifepristone and Misoprostol for Fetal Demise

MIMID
Start date: January 2005
Phase: Phase 4
Study type: Interventional

This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment. Subjects with early pregnancy failure receive mifepristone followed 24 hours later by vaginal misoprostol for medical management. Subjects then return on study day 3 for a repeat ultrasound to assess passage of pregnancy tissue. subjects who still have a gestational sac present at Day 3 receive a second dose of vaginal misoprostol. All subjects have a follow-up at Day 15, by phone for those who passed the pregnancy with the first dose of misoprostol, and in person for those who received a second dose. Questionnaires are administered at the beginning and end of the study to determine acceptability.